Maharashtra Health Minister
Rajesh Tope on Thursday said the state is being allocated 26,000 Remdesivir injections per day by the Centre as against the requirement of 50,000 vials of the anti-COVID-19 drug.
Talking to reporters here, Tope said he will write to the Centre to increase the allocation of Remdesivir to Maharashtra, the worst COVID-19-hit state in the country.
"The state government's daily requirement is 50,000 Remdesivir injections, but the Centre's allocation is 26,000 injections per day. This is for the next 10 days, which is very serious as timely use of the injections to treat co- morbid and serious COVID-19 patients can save lives," he said.
Remdesivir is listed for use in serious COVID-19 patients. In view of a sudden spike in demand of the drug due to the surge in COVID-19 cases, the Centre last week banned its export till the situation improves.
"I will send a letter to the Union Health Ministry on Thursday to increase the allocation of the key anti-viral drug to Maharashtra," the minister said.
Tope and state Food and Drug Administration minister Rajendra Shingane few days ago had assured that the supply of Remdesivir will increase from April 21.
On Wednesday, the state reported 67,468 fresh coronavirus cases, taking its tally beyond the 40-lakh mark, while 568 more patients succumbed to the infection, as per the health department.
The Bombay High Court on Wednesday came down heavily on the Maharashtra government for its "extremely callous" behaviour towards the issue of procuring and allocating Remdesivir injections for COVID-19 patients, and said the authorities are shirking their responsibilities.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)